Sfoglia per Autore
L-arginine supplementation in pulmonary arterial hypertension
2004 Manes A; Bautista E; Olchewski H; Torbicki A; Galie N
Effetti clinici ed emodinamici del trattamento con sildenafil nei pazienti con ipertensione arteriosa polmonare.
2004 Manes A; Negro L; Vaziri Farahani K; Pelino F; Palazzini M; Romanazzi S; Galie N; Branzi A.
Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology
2004 Galie N; Torbicki A; Barst R; Dartevelle P; Haworth S; Higenbottam T; Olschewski H; Peacock A; Pietra G; Rubin LJ; Simonneau G; Priori SG; Garcia MA; Blanc JJ; Budaj A; Cowie M; Dean V; Deckers J; Burgos EF; Lekakis J; Lindahl B; Mazzotta G; McGregor K; Morais J; Oto A; Smiseth OA; Barbera JA; Gibbs S; Hoeper M; Humbert M; Naeije R; Pepke-Zaba J
The endothelin system in pulmonary arterial hypertension.
2004 GALIE N; MANES A; BRANZI A.
Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension.
2004 Galie N; Seeger W; Naeije R; Simonneau G; Rubin LJ.
Introduction: New insights into a challenging disease - A review of the Third World Symposium on Pulmonary Arterial Hypertension
2004 Galie N; Rubin LJ
Clinical classification of pulmonary hypertension.
2004 Simonneau G; Galie N; Rubin LJ; Langleben D; Seeger W; Domenighetti G; Gibbs S; Lebrec D; Speich R; Beghetti M; Rich S; Fishman A.
New insights on pulmonary arterial hypertension.
2004 GALIE N; MANES A; BRANZI A.
Pulmonary arterial hypertension: a look to the future.
2004 Rubin LJ; Galie N.
Effetti a lungo termine del trattamento con bosentan sulla capacità funzionale e sui parametri emodinamici nei pazienti con ipertensione arteriosa polmonare.
2004 Vaziri Farahani K; Boggian G; Manes A; Pelino F; Romanazzi S; Palazzini M; Negro L; Galie N; Branzi A.
Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2.
2004 Humbert M; Barst RJ; Robbins IM; Channick RN; Galie N; Boonstra A; Rubin LJ; Horn EM; Manes A; Simonneau G
Long-term benefits of ambrisentan in patients with pulmonary arterial hypertension: a comparison by etiology and baseline functional class
2005 Galie N; Frost A; Keogh A Zwicke; D Oudiz R; Naeije R; Olschewsky H; Rubin L.
Significato prognostico dell'aerea del rigurgito tricuspidalico nei pazienti con ipertensione arteriosa polmonare idiopatica trattati secondo le attuali linee guida.
2005 Manes A; Rocchi G; Ferlito M; Vaziri Farahani K; Romanazzi S; Negro L; Palazzini M; Presotto L; Marinelli A; Gambetti S; Leci E; Galie N; Branzi A
Sitaxsentan improves time to clinical worsening in patients with pulmonary arterial hypertension (PAH).
2005 Badesch D; Galie N; Langleben D; Naeije R; Simonneau G; Barst RJ
Long-term efficacy and safety of sildenafil in precapillary pulmonary hypertension
2005 Manes A; Negro L; Farahani K. Vaziri; Pelino F; Romanazzi S; Palazzini M; Galie' N; Branzi A
Regressione delle alterazioni elettrocardiografiche indicative di ipertrofia ventricolare destra nei pazienti con ipertensione arteriosa polmonare.
2005 Vaziri Farahani K; Romanazzi S; Palazzini M; Negro L; Presotto L; Marinelli A; Gambetti S; Leci E; Manes A; Galie N; Branzi A.
Il test acuto di vasoreattività nei pazienti con ipertensione arteriosa polmonare.
2005 Negro L; Manes A; Leci E; Gambetti S; Marinelli A; Presotto L; Romanazzi S; Vaziri Farahani K; Palazzini M; Galie N; Branzi A.
Sitaxsentan, a selective endothelin-A receptor antagonist, improves exercise capacity in pulmonary arterial hypertension (PAH) associated with connective tissue disease (CTD).
2005 Seibold JR; Langleben D; Badesch D; Naeije E; Simonneau G; Galie N; Barst RJ
Sitaxsentan, a selective endothelin-A receptor antagonist, improves exercise capacity in pulmonary arterial hypertension (PAH) associated with connective tissue disease (CTD)
2005 Seibold J; Badesch D; Galie N; Langleben D; Naeije R; Simonneau G; Barst R
Effects of sildenafil on 1-year survival of patients with idiopathic pulmonary arterial hypertension (PAH
2005 Galie N;Burgess G;Parpia T; Rubin L.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile